Lansforsakringar Fondforvaltning AB publ Buys 42,803 Shares of Kenvue Inc. $KVUE

Posted by on Jul 2nd, 2026

Lansforsakringar Fondforvaltning AB publ raised its stake in shares of Kenvue Inc. (NYSE:KVUE – Free Report) by 7.3% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 630,410 shares of the company’s stock after buying an additional 42,803 shares during the quarter. Lansforsakringar Fondforvaltning AB publ’s holdings in Kenvue were worth $10,868,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Oak Thistle LLC purchased a new position in shares of Kenvue during the 4th quarter valued at $1,563,000. Mirae Asset Global Investments Co. Ltd. boosted its stake in Kenvue by 25.8% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 410,874 shares of the company’s stock valued at $7,088,000 after buying an additional 84,219 shares during the period. SG Americas Securities LLC boosted its stake in Kenvue by 3,889.9% during the fourth quarter. SG Americas Securities LLC now owns 3,075,723 shares of the company’s stock valued at $53,056,000 after buying an additional 2,998,635 shares during the period. Moors & Cabot Inc. grew its position in Kenvue by 66.9% during the third quarter. Moors & Cabot Inc. now owns 313,122 shares of the company’s stock worth $5,082,000 after buying an additional 125,517 shares in the last quarter. Finally, Cohen Capital Management Inc. purchased a new position in Kenvue during the fourth quarter worth about $2,448,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.59% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on KVUE. Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Citigroup cut their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Argus upgraded shares of Kenvue to a “hold” rating in a research report on Friday, March 6th. Barclays lowered their target price on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. Finally, Zacks Research upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $19.33.

View Our Latest Stock Report on Kenvue

Kenvue Trading Up 1.1%

Shares of KVUE stock opened at $19.33 on Thursday. The business has a 50-day moving average of $17.76 and a 200 day moving average of $17.68. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $22.87. The stock has a market capitalization of $37.11 billion, a PE ratio of 22.74, a P/E/G ratio of 1.45 and a beta of 0.54.

Kenvue (NYSE:KVUE – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $3.84 billion. During the same period in the previous year, the firm earned $0.24 EPS. The business’s quarterly revenue was up 4.5% on a year-over-year basis. As a group, sell-side analysts anticipate that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.3%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s payout ratio is presently 97.65%.

Kenvue Company Profile

(Free Report)

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Featured Articles

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE – Free Report).

Institutional Ownership by Quarter for Kenvue (NYSE:KVUE)

Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.